ホーム>>Signaling Pathways>> Proteases>> Endogenous Metabolite>>4'-O-methyl Quercetin

4'-O-methyl Quercetin (Synonyms: 4'-methoxy Quercetin, Tamarixetin)

カタログ番号GC41003

4'-O-メチル ケルセチン (4'-O-メチル ケルセチン) は、ケルセチンの天然フラボノイド誘導体で、抗酸化作用と抗炎症作用があります。

Products are for research use only. Not for human use. We do not sell to patients.

4'-O-methyl Quercetin 化学構造

Cas No.: 603-61-2

サイズ 価格 在庫数 個数
500μg
$54.00
在庫あり
1mg
$102.00
在庫あり
5mg
$255.00
在庫あり
10mg
$428.00
在庫あり

Tel:(909) 407-4943 Email: sales@glpbio.com


顧客レビュー

カスタマーレビューに基づきます。

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

4'-O-methyl Quercetin is a flavonoid isolated from C. ordata with anticancer and antiplasmodial activity. 4'-O-methyl Quercetin is a major metabolite of quercetin that inhibits the viability of HL-60, U937, MOLT-3, Raji, K562, MCF-7, SK-MEL-1, and A549 human tumor cell lines with IC50 values ranging from 5.5-24.1 μM. It induces G2-M arrest and inhibits tubulin polymerization in vitro in a dose-dependent manner. 4'-O-methyl Quercetin inhibits breast cancer resistance protein (BCRP/ABCG2; IC50 = 40 nM in a vesicular transport assay) with no cellular toxicity indicating potential for use in overcoming multidrug resistance in chemotherapy. 4'-O-methyl Quercetin also reduces in vitro proliferation of chloroquine-resistant P. falciparum (IC50 = 4.8 μM) and suppresses infection in mice (65-81% suppression at 2.5-5 mg/kg dose).

レビュー

Review for 4'-O-methyl Quercetin

Average Rating: 5 ★★★★★ (Based on Reviews and 13 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for 4'-O-methyl Quercetin

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.